Skip to the page

Data / Form D filings / CytoTronics, Inc.

CytoTronics, Inc.: Form D filing

CytoTronics, Inc., a technology company in Boston, MA, filed a Form D with the SEC in 2024. The latest, on October 11, 2024, reports $13.5 million sold of a $13.5 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
38 Wareham Street, Boston, MA, 02118
Phone
(714) 671-9704
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2036555

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 11, 2024New notice$13,500,000$13,500,00010Mar 22, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sameer RohatgiDirector
Jeffrey AbbottExecutive Officer, Director
Douglas KahnDirector
Wenxuan WuExecutive Officer, Director
Jenna AbelliDirector

Other technology companies in Massachusetts that filed recently

Every Form D from the week of Oct 7, 2024 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what CytoTronics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.